v3 Template
Q

Quthero

Biotechnology / Healthcare ~480 employees
Founded
--
Employees (Est.)
~480
24 leaders known
Total Funding
$500K
Funding Rounds
1
Last Funding
2024-03-11

About Quthero

Quthero is a privately held company focused on advancing regenerative therapies using its proprietary Q-peptide technology, with applications in dermatology and cardiology. The company aims to reimagine healing by leveraging the regenerative and anti-inflammatory properties of Q-peptide, a synthetic bioactive peptide derived from Angiopoietin-1.

Products & Services

Q-peptide Technology Platform:A versatile platform for regenerative therapies with applications where cell survival, anti-inflammatory effects, and regenerative support are critical. It modifies inflammatory responses, accelerates healing, reduces redness and swelling, and improves skin texture.
Cardiovascular Health Solutions:Therapies targeting regeneration of blood supply in damaged or ischemic tissues, such as after heart attacks or in peripheral artery disease, by promoting blood vessel stabilization.
Post-Aesthetic Procedure Healing Products:Products like Kerra, featuring Q-peptide, designed to accelerate healing, reduce redness and swelling, and improve skin quality after aesthetic procedures.
Wound Healing and Regeneration:Solutions focused on accelerating cell migration and collagen deposition for faster healing of wounded skin.

Specialties

Regenerative Therapies Q-peptide Technology Dermatology Cardiology Anti-inflammatory Treatments Vascular Health

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Venture Capital
T: -
FT: Venture Capital 		A: 500000
MR: -
FA: $500,000
FAN: 500000 		D: 2024-03-11
FD: 2024-03-11 		1 investors
Venture Capital Latest
2024-03-11
$500K
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

K

Karen Cronholm

CBO

LinkedIn (Pro only)
M

Mike Williams

CCO

LinkedIn (Pro only)
D

Dawn Bannerman

Senior Scientist

LinkedIn (Pro only)
A

Alaa Alsaafin

M

Milica Radisic

CEO & Founder

S

Susan Bruggemann

COO, CFO

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

Quthero Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~480 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro